From: A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression
Ropivacaine
Placebo
Gender, (female/male)
11/16
11/12
Age, yr.
53 (32–74)
53 (35–75)
Height, cm
173 (164–198)
171 (160–200)
Weight, kg
79 (51–108)
79 (53–130)
BMI, kg/m2
26 (21–35)
26 (21–33)
Dynamic pain, VAS (baseline)
68 (10–100)
67 (4–100)